Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jenny Gunnarsson
Observed names:
Gunnarsson, Jenny,
J Gunnarsson,
J. Gunnarsson
Institutions:
Sahlgrenska University Hospital,
AstraZeneca (Sweden)
Observed institutions:
Sahlgrenska University Hospital,
Hallands sjukhus Kungsbacka,
Kungälvs Sjukhus,
AstraZeneca (Sweden),
University of Gothenburg
ORCID:
0009-0006-1547-0306
Observed ORCID:
0009-0006-1547-0306
OpenAlex ID:
A5002208020
Randomized clinical trial: inhibition of the TRPV1 system in patients with nonerosive gastroesophageal reflux disease and a partial response to PPI treatment is not associated with analgesia to esophageal experimental pain
2013
·
Anne Lund Krarup
, Lars Ny
, et al.
·
Scandinavian Journal of Gastroenterology
·
157
Peripheral factors in the pathophysiology of irritable bowel syndrome
2009
·
J. Gunnarsson
, M. Simrén
·
Digestive and Liver Disease
·
62
Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study
2021
·
Carl Eriksson
, Sara Rundquist
, et al.
·
Therapeutic Advances in Gastroenterology
·
30
PDF
Efficient diagnosis of suspected functional bowel disorders
2008
·
Jenny Gunnarsson
, Magnus Simrén
·
Nature Clinical Practice Gastroenterology & Hepatology
·
25
Exploration of the effects of gender and mild esophagitis on esophageal pain thresholds in the normal and sensitized state of asymptomatic young volunteers
2013
·
A. L. Krarup
, J. Gunnarsson
, et al.
·
Neurogastroenterology & Motility
·
10
P758 Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with Crohn’s disease (SVEAH CD)
2018
·
C Eriksson
, S Rundquist
, et al.
·
Journal of Crohn s and Colitis
·
2
P547 Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with ulcerative colitis (SVEAH UC)
2018
·
C Eriksson
, S Rundquist
, et al.
·
Journal of Crohn s and Colitis
·
1
P364 A Swedish observational study (SVEAH) on vedolizumab assessing effectiveness and healthcare resource utilization in patients with inflammatory bowel disease
2017
·
C. Eriksson
, S. Rundquist
, et al.
·
Journal of Crohn s and Colitis
·
1
W1247 IBS Patients Have Normal and Abnormal Bowel Habits: Relevance for Subtyping?
2009
·
Magnus Simren
, Iris Posserud
, et al.
·
Gastroenterology
·
1
ULK1 knockout increases recombinant transcript abundance and improves recombinant membrane protein expression
2026
·
Alice Karlsson
, Melanie Dannemeyer
, et al.
·
Cell Systems
Adalimumab and infliximab are equally efficient in achieving sustained remission in ulcerative colitis but infliximab is superior in severe disease—a retrospective observational study
2026
·
Gunnarsson, Jenny
, Mavroudis, Georgios
, et al.
·
Figshare
Adalimumab and infliximab are equally efficient in achieving sustained remission in ulcerative colitis but infliximab is superior in severe disease—a retrospective observational study
2026
·
Jenny Gunnarsson
, Georgios Mavroudis
, et al.
·
Scandinavian Journal of Gastroenterology
PDF
P0930 Adalimumab is equally efficient as infliximab in achieving sustained remission in Ulcerative Colitis but inferior in patients with severe disease
2025
·
J Gunnarsson
, G Mavroudis
, et al.
·
Journal of Crohn s and Colitis
PDF
Mo1886 REAL-WORLD EFFECTIVENESS OF VEDOLIZUMAB IN CROHN'S DISEASE: WEEK 52 RESULTS FROM THE SWEDISH MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL SVEAH CD STUDY
2020
·
Carl Eriksson
, Sara Rundquist
, et al.
·
Gastroenterology
P714 Real-world effectiveness of vedolizumab in ulcerative colitis: Week 52 results from the Swedish multi-centre, prospective, observational SVEAH UC study
2020
·
C ERIKSSON
, S Rundquist
, et al.
·
Journal of Crohn s and Colitis
PDF
Mo1892 - Clinical Effectiveness of Vedolizumab: Interim Analysis of the Swedish Observational Study on Vedolizumab Assessing Effectiveness and Healthcare Resource Utilization in Patients with Crohn's Disease (Sveah CD)
2018
·
Carl Eriksson
, Sara Rundquist
, et al.
·
Gastroenterology
The Esophageal multimodal pain model:Exploration of gender differences in pain thresholds in the normal and sensitized state of healthy volunteers
2013
·
Krarup, Anne
, Gunnarsson, Jenny
, et al.
·
VBN Forskningsportal (Aalborg Universitet)
Mo1073 Randomized Clinical Trial: Inhibition of the TRPV1-System in Patients With Gastro-Esophageal Reflux Disease Has No Analgesic Effect on the Response to Esophageal Experimental Pain
2012
·
Anne L. Krarup
, Lars Ny
, et al.
·
Gastroenterology
Fasting and Postprandial Rectal Hypersensitivity in IBS Patients
2011
·
Hans Törnblom
, Jenny Gunnarsson
, et al.
·
Gastroenterology
Psychological Factors and Esophageal Acid Exposure Are of Importance in Patients With Chest Pain Not Explained by Cardiac Causes
2011
·
Jenny Gunnarsson
, Jenny Wallin
, et al.
·
Gastroenterology
PDF
Irritable Bowel Syndrome
2011
·
Jenny Gunnarsson
, Syndrom
, et al.
M1239 Gastrointestinal-Specific Anxiety and Somatization Are Important Determinants for Symptom Severity in Irritable Bowel Syndrome
2009
·
Jenny Gunnarsson
, Iris Posserud
, et al.
·
Gastroenterology
W1722 Rectal Sensorimotor Dysfunction in the Fasting State and After Meal Intake in Irritable Bowel Syndrome
2009
·
Jenny Gunnarsson
, Iris Posserud
, et al.
·
Gastroenterology
874 Visceral Hypersensitivity and Somatization Are of Importance for Meal-Related GI Symptom Severity in Irritable Bowel Syndrome
2009
·
Jenny Gunnarsson
, Iris Posserud
, et al.
·
Gastroenterology
T1445 Is Visceral Hypersensitivity in Irritable Bowel Syndrome Due to Sensitisation of Pain-Selective or Multimodal Afferent Pathways?
2008
·
Jenny Gunnarsson
, Iris Posserud
, et al.
·
Gastroenterology
PDF
Show more works
View as search
Works count:
28
Citation count:
289
H-index:
5
I10-index:
5
Year
Topic
Type